Adaptive clinical trial designs for phase I cancer studies (Q2452091): Difference between revisions

From MaRDI portal
Changed an Item
Set OpenAlex properties.
 
(2 intermediate revisions by 2 users not shown)
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4284864 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4699450 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Cumulative cohort design for dose-finding / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: The treatment versus experimentation dilemma in dose finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Übersichtsarbeiten / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal Design for Nonlinear Response Models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Optimal Designs for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Approximate dynamic programming and its applications to the design of Phase I cancer trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive designs for dose-finding based on efficacy-toxicity response / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stochastic approximation and modern model-based designs for dose-finding clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Coherence principles in dose-finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical Methods for Dose‐Finding Experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Small-Sample Confidence Sets for the MTD in a Phase I Clinical Trial / rank
 
Normal rank
Property / cites work
 
Property / cites work: Operating characteristics of the standard phase I clinical trial design. / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5434036 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Existence of three solutions to a second-order nonhomogeneous multipoint boundary-value problem / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4699451 / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Method for Obtaining and Analyzing Sensitivity Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Toxicity in sequential dose-response experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Random Walk Rule for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Up-and-down experiments of first and second order / rank
 
Normal rank
Property / cites work
 
Property / cites work: Asymptotic normality of maximum likelihood estimators from multiparameter response-driven designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: THE DISTRIBUTION OF THE MAXIMUM LIKELIHOOD ESTIMATOR IN UP-AND-DOWN EXPERIMENTS FOR QUANTAL DOSE-RESPONSE DATA / rank
 
Normal rank
Property / cites work
 
Property / cites work: Properties of frequency distributions induced by general ''up-and-down'' methods for estimating quantiles / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose Finding Using the Biased Coin Up-and-Down Design and Isotonic Regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: Derivation of Exact Distributions Following an Up-and-Down Design / rank
 
Normal rank
Property / cites work
 
Property / cites work: Group up-and-down designs for dose-finding / rank
 
Normal rank
Property / cites work
 
Property / cites work: Randomized group up and down experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4699452 / rank
 
Normal rank
Property / cites work
 
Property / cites work: A New Dose‐Finding Design for Bivariate Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Single- or Multiple-Agent Phase I Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual reassessment and related dose-finding designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Consistency of continual reassessment method under model misspecification / rank
 
Normal rank
Property / cites work
 
Property / cites work: Theoretical study of the continual reassessment method / rank
 
Normal rank
Property / cites work
 
Property / cites work: A note on the robustness of the continual reassessment method / rank
 
Normal rank
Property / cites work
 
Property / cites work: Non-parametric optimal design in dose finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design efficiency in dose finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Curve‐Free Method for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Curve-Free and Model-Based Continual Reassessment Method Designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance / rank
 
Normal rank
Property / cites work
 
Property / cites work: A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches / rank
 
Normal rank
Property / cites work
 
Property / cites work: Robust EM Continual Reassessment Method in Oncology Dose Finding / rank
 
Normal rank
Property / cites work
 
Property / cites work: Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design / rank
 
Normal rank
Property / cites work
 
Property / cites work: Miscellanea. A stopping rule for the continual reassessment method / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual reassessment designs with early termination / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities / rank
 
Normal rank
Property / cites work
 
Property / cites work: Monitoring late-onset toxicities in phase I trials using predicted risks / rank
 
Normal rank
Property / cites work
 
Property / cites work: TWO-SAMPLE CONTINUAL REASSESSMENT METHOD / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method for Ordered Groups / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs foe phase i cancer clinical trials with differentiation of graded toxicity / rank
 
Normal rank
Property / cites work
 
Property / cites work: The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method for Partial Ordering / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Based on Feasibility and Toxicity in T-cell Infusion Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Designs for HIV Studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose finding with escalation with overdose control (EWOC) in cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control / rank
 
Normal rank
Property / cites work
 
Property / cites work: Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Number of patients per cohort and sample size considerations using dose escalation with overdose control / rank
 
Normal rank
Property / cites work
 
Property / cites work: Unifying CRM and EWOC designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian decision procedures based on logistic regression models for dose-finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Adaptive Bayesian compound designs for dose finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Convergence properties of sequential Bayesian \(D\)-optimal designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Semiparametric Sequential Algorithm for Estimation of Dose–Response Curve / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs for Dose Escalation Studies in Oncology / rank
 
Normal rank
Property / cites work
 
Property / cites work: Approximate policy optimization and adaptive control in regression models / rank
 
Normal rank
Property / cites work
 
Property / cites work: A new look at evaluating MTD designs in cancer research / rank
 
Normal rank
Property / cites work
 
Property / cites work: Retrospective Analysis of Sequential Dose‐Finding Designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Stochastic Approximation Method / rank
 
Normal rank
Property / cites work
 
Property / cites work: Efficient Sequential Designs With Binary Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs in Bioassay / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stochastic approximation with virtual observations for dose-finding on discrete levels / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding with Two Agents in Phase I Oncology Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Two‐Dimensional Dose Finding in Discrete Dose Space / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian dose finding for combined drugs with discrete and continuous doses / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian models and decision algorithms for complex early phase clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients / rank
 
Normal rank
Property / cites work
 
Property / cites work: Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W1975592428 / rank
 
Normal rank

Latest revision as of 10:00, 30 July 2024

scientific article
Language Label Description Also known as
English
Adaptive clinical trial designs for phase I cancer studies
scientific article

    Statements

    Adaptive clinical trial designs for phase I cancer studies (English)
    0 references
    0 references
    0 references
    0 references
    30 May 2014
    0 references
    Bayesian designs
    0 references
    ``best intention'' designs
    0 references
    continual reassessment method
    0 references
    dose finding studies
    0 references
    estimation efficiency
    0 references
    ethics
    0 references
    maximum tolerated dose
    0 references
    oncology trial designs
    0 references
    optimal designs
    0 references
    phase I
    0 references
    stochastic approximation
    0 references
    toxicity
    0 references
    up-and-down designs
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references